CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 103  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0661
LYS 10.0316
GLU 20.0247
LEU 30.0187
ARG 40.0311
CYS 50.0104
GLN 60.0369
CYS 70.0661
ILE 80.0263
LYS 90.0219
THR 100.0364
TYR 110.0288
SER 120.0133
LYS 130.0291
PRO 140.0155
PHE 150.0219
HIS 160.0087
PRO 170.0164
LYS 180.0188
PHE 190.0085
ILE 200.0063
LYS 210.0088
GLU 220.0037
LEU 230.0103
ARG 240.0139
VAL 250.0156
ILE 260.0217
GLU 270.0114
SER 280.0424
GLY 290.0561
PRO 300.0449
HIS 310.0325
CYS 320.0122
ALA 330.0202
ASN 340.0328
THR 350.0162
GLU 360.0208
ILE 370.0121
ILE 380.0060
VAL 390.0059
LYS 400.0112
LEU 410.0119
SER 420.0167
ASP 430.0152
GLY 440.0160
ARG 450.0127
GLU 460.0062
LEU 470.0103
CYS 480.0163
LEU 490.0140
ASP 500.0119
PRO 510.0224
LYS 520.0488
GLU 530.0177
ASN 540.0147
TRP 550.0113
VAL 560.0147
GLN 570.0101
ARG 580.0147
VAL 590.0110
VAL 600.0104
GLU 610.0047
LYS 620.0129
PHE 630.0054
LEU 640.0031
LYS 650.0126
ARG 660.0073
ALA 670.0092
GLU 680.0144
ASN 690.0195

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.